207 related articles for article (PubMed ID: 24304919)
1. DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.
Tan Y; Shi YS; Wu XD; Liang HY; Gao YB; Li SJ; Zhang XM; Wang F; Gao TM
Acta Pharmacol Sin; 2013 Dec; 34(12):1491-8. PubMed ID: 24304919
[TBL] [Abstract][Full Text] [Related]
2. Cell-SELEX aptamer for highly specific radionuclide molecular imaging of glioblastoma in vivo.
Wu X; Liang H; Tan Y; Yuan C; Li S; Li X; Li G; Shi Y; Zhang X
PLoS One; 2014; 9(6):e90752. PubMed ID: 24603483
[TBL] [Abstract][Full Text] [Related]
3. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
4. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
5. [Cell-ELA-based determination of binding affinity of DNA aptamer against U87-EGFRvIII cell].
Tan Y; Liang H; Wu X; Gao Y; Zhang X
Sheng Wu Gong Cheng Xue Bao; 2013 May; 29(5):664-71. PubMed ID: 24010364
[TBL] [Abstract][Full Text] [Related]
6. Pyrene-Modified DNA Aptamers with High Affinity to Wild-Type EGFR and EGFRvIII.
Zavyalova E; Turashev A; Novoseltseva A; Legatova V; Antipova O; Savchenko E; Balk S; Golovin A; Pavlova G; Kopylov A
Nucleic Acid Ther; 2020 Jun; 30(3):175-187. PubMed ID: 31990606
[TBL] [Abstract][Full Text] [Related]
7. Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.
Liu Y; Kuan CT; Mi J; Zhang X; Clary BM; Bigner DD; Sullenger BA
Biol Chem; 2009 Feb; 390(2):137-44. PubMed ID: 19040357
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma.
Peng L; Liang Y; Zhong X; Liang Z; Tian Y; Li S; Liang J; Wang R; Zhong Y; Shi Y; Zhang X
Int J Nanomedicine; 2020; 15():1363-1372. PubMed ID: 32184591
[TBL] [Abstract][Full Text] [Related]
9. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
10. Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells.
Zhang X; Peng L; Liang Z; Kou Z; Chen Y; Shi G; Li X; Liang Y; Wang F; Shi Y
Mol Ther Nucleic Acids; 2018 Mar; 10():438-449. PubMed ID: 29499954
[TBL] [Abstract][Full Text] [Related]
11. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.
Schulte A; Liffers K; Kathagen A; Riethdorf S; Zapf S; Merlo A; Kolbe K; Westphal M; Lamszus K
Neuro Oncol; 2013 Oct; 15(10):1289-301. PubMed ID: 23877316
[TBL] [Abstract][Full Text] [Related]
13. DNA aptamers from whole-cell SELEX as new diagnostic agents against glioblastoma multiforme cells.
Wu Q; Wang Y; Wang H; Wu L; Zhang H; Song Y; Zhu Z; Kang D; Yang C
Analyst; 2018 May; 143(10):2267-2275. PubMed ID: 29708252
[TBL] [Abstract][Full Text] [Related]
14. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
15. Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.
Wu Q; Wu L; Wang Y; Zhu Z; Song Y; Tan Y; Wang XF; Li J; Kang D; Yang CJ
Biosens Bioelectron; 2016 Jun; 80():1-8. PubMed ID: 26802746
[TBL] [Abstract][Full Text] [Related]
16. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.
Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL
J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cell proliferation by an anti-EGFR aptamer.
Li N; Nguyen HH; Byrom M; Ellington AD
PLoS One; 2011; 6(6):e20299. PubMed ID: 21687663
[TBL] [Abstract][Full Text] [Related]
18. Development of DNA aptamers using Cell-SELEX.
Sefah K; Shangguan D; Xiong X; O'Donoghue MB; Tan W
Nat Protoc; 2010 Jun; 5(6):1169-85. PubMed ID: 20539292
[TBL] [Abstract][Full Text] [Related]
19. A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death.
Esposito CL; Passaro D; Longobardo I; Condorelli G; Marotta P; Affuso A; de Franciscis V; Cerchia L
PLoS One; 2011; 6(9):e24071. PubMed ID: 21915281
[TBL] [Abstract][Full Text] [Related]
20. Generation of Aptamers from A Primer-Free Randomized ssDNA Library Using Magnetic-Assisted Rapid Aptamer Selection.
Tsao SM; Lai JC; Horng HE; Liu TC; Hong CY
Sci Rep; 2017 Apr; 7():45478. PubMed ID: 28367958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
